Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Holtzman

Showing results (61-70 of 602) with videos related to

Pageof 61
Sort By:
Immunological Reviews|October 24, 2024
Current insights into apolipoprotein E and the immune response in Alzheimer's diseasePeter Bor-Chian Lin, David M Holtzman
Neurobiology of Sleep and Circadian Rhythms|February 21, 2017
Sleep in Alzheimer's Disease - Beyond AmyloidJerrah Holth, Tirth Patel, David M Holtzman
Immunity|February 27, 2026
Immunity in Alzheimer's disease: From mechanisms to therapiesXiaoying Chen, David M Holtzman, Marco Colonna
Trends in Neurosciences|July 29, 2018
In Search of an Identity for Amyloid PlaquesTien-Phat V Huynh, David M Holtzman
Molecular Neurodegeneration|July 1, 2017
Glial contributions to neurodegeneration in tauopathiesCheryl E G Leyns, David M Holtzman
Developmental Neuroscience|September 1, 2007
Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injuryTim West, Madeliene Atzeva, David M Holtzman
JAMA Neurology|August 14, 2013
Sleep evaluation by actigraphy for patients with Alzheimer disease--replyYo-El S Ju, David M Holtzman
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer diseaseDavid M Holtzman, Joachim Herz, Guojun Bu
Neurobiology of Disease|February 17, 2006
Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathwaysTim West, Madeliene Atzeva, David M Holtzman
Annals of Neurology|December 27, 2016
ReplyYo-El S Ju, David M Holtzman
Pageof 61

Showing results (61-70 of 602) with videos related to

Sort By:
Pageof 61
Immunological Reviews|October 24, 2024
Current insights into apolipoprotein E and the immune response in Alzheimer's diseasePeter Bor-Chian Lin, David M Holtzman
Neurobiology of Sleep and Circadian Rhythms|February 21, 2017
Sleep in Alzheimer's Disease - Beyond AmyloidJerrah Holth, Tirth Patel, David M Holtzman
Immunity|February 27, 2026
Immunity in Alzheimer's disease: From mechanisms to therapiesXiaoying Chen, David M Holtzman, Marco Colonna
Trends in Neurosciences|July 29, 2018
In Search of an Identity for Amyloid PlaquesTien-Phat V Huynh, David M Holtzman
Molecular Neurodegeneration|July 1, 2017
Glial contributions to neurodegeneration in tauopathiesCheryl E G Leyns, David M Holtzman
Developmental Neuroscience|September 1, 2007
Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injuryTim West, Madeliene Atzeva, David M Holtzman
JAMA Neurology|August 14, 2013
Sleep evaluation by actigraphy for patients with Alzheimer disease--replyYo-El S Ju, David M Holtzman
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer diseaseDavid M Holtzman, Joachim Herz, Guojun Bu
Neurobiology of Disease|February 17, 2006
Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathwaysTim West, Madeliene Atzeva, David M Holtzman
Annals of Neurology|December 27, 2016
ReplyYo-El S Ju, David M Holtzman
Pageof 61